Clinical Trial Update: Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs [NA]

View source ↗

Summary

An update on a clinical trial evaluating whether prophylactic use of silymarin can reduce hepatotoxicity caused by anti-tuberculosis drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Tuberculosis | NA | Status: UNKNOWN